Active, not recruitingNCT05991609
Extreme Morphology and Metabolic Health
Studying OBSOLETE: Epimetaphyseal skeletal dysplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Bath
- Principal Investigator
- James A Betts, PhDUniversity of Bath
- Enrollment
- 102 enrolled
- Eligibility
- 16 years · All sexes
- Timeline
- 2023 – 2035
Study locations (1)
- University of Bath, Bath, United Kingdom
Collaborators
University of Bristol
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05991609 on ClinicalTrials.govOther trials for OBSOLETE: Epimetaphyseal skeletal dysplasia
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Epimetaphyseal skeletal dysplasia →